Plain-English translation of NCT06771011 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing two different scoring systems — called RECAM and RUCAM — to see which one is better at identifying drug-induced liver injury. Researchers will collect medical information from patients who have developed liver injury after taking medication, and have three independent doctors score each patient using both systems to compare how well they work.
Drug-induced liver injury is a serious condition that can be hard to diagnose accurately. By comparing these two scoring systems, doctors hope to find the best way to quickly and reliably identify when a medication is the cause of someone's liver problems, so they can stop the drug and provide proper treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, doctors will review your medical records, blood test results, and imaging scans that you've already had done at the hospital. Three independent doctors will independently score your case using both scoring systems to see which one is more accurate. You will not need to take any new medications or undergo additional procedures — the study uses information that has already been collected as part of your hospital care.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
China
Sponsor
Beijing Friendship Hospital
Enrollment target
~407 participants
Started
May 2023
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xinyan Zhao
Beijing Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.